Xuefu Wang

1.4k total citations
57 papers, 956 citations indexed

About

Xuefu Wang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Xuefu Wang has authored 57 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Xuefu Wang's work include Immune Cell Function and Interaction (19 papers), T-cell and B-cell Immunology (9 papers) and Advanced Numerical Analysis Techniques (7 papers). Xuefu Wang is often cited by papers focused on Immune Cell Function and Interaction (19 papers), T-cell and B-cell Immunology (9 papers) and Advanced Numerical Analysis Techniques (7 papers). Xuefu Wang collaborates with scholars based in China, United States and Taiwan. Xuefu Wang's co-authors include Zhigang Tian, Haiming Wei, Rui Sun, Fuhua Cheng, Jiacheng Bi, Brian A. Barsky, Lijun Xu, Zhe‐Xiong Lian, Shanshan Wang and Feng Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Xuefu Wang

55 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefu Wang China 18 391 220 168 127 93 57 956
Yanxiang Zhang China 17 127 0.3× 221 1.0× 135 0.8× 81 0.6× 25 0.3× 54 834
Junhua Gong China 15 139 0.4× 318 1.4× 96 0.6× 126 1.0× 89 1.0× 57 722
Jin Zhao China 19 292 0.7× 354 1.6× 218 1.3× 64 0.5× 20 0.2× 67 1.1k
Jun Matsumoto Japan 18 181 0.5× 207 0.9× 96 0.6× 147 1.2× 44 0.5× 128 1.1k
Nan Cheng China 20 195 0.5× 434 2.0× 117 0.7× 72 0.6× 20 0.2× 53 1.0k
Jinkun Zhang China 16 175 0.4× 317 1.4× 101 0.6× 123 1.0× 47 0.5× 61 1.3k
Jun Ren United States 23 488 1.2× 574 2.6× 180 1.1× 128 1.0× 53 0.6× 53 1.6k
Hiroshi Sakurai Japan 13 200 0.5× 185 0.8× 72 0.4× 94 0.7× 22 0.2× 42 928

Countries citing papers authored by Xuefu Wang

Since Specialization
Citations

This map shows the geographic impact of Xuefu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefu Wang more than expected).

Fields of papers citing papers by Xuefu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefu Wang. The network helps show where Xuefu Wang may publish in the future.

Co-authorship network of co-authors of Xuefu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefu Wang. A scholar is included among the top collaborators of Xuefu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefu Wang. Xuefu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Fei, Yuanyuan Feng, Wenqiang Ma, et al.. (2025). Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells. International Immunopharmacology. 147. 113971–113971. 2 indexed citations
2.
Li, Y, Xi Chen, Jialong Zhang, et al.. (2025). GPR35 prevents drug-induced liver injury via the Gαs-cAMP-PKA axis in macrophages. Cellular and Molecular Life Sciences. 82(1). 219–219. 2 indexed citations
3.
Zhao, Xueqin, Fei Li, Cheng Chen, et al.. (2024). Social isolation promotes tumor immune evasion via β2-adrenergic receptor. Brain Behavior and Immunity. 123. 607–618. 7 indexed citations
4.
Chen, Xiangyu, et al.. (2024). Assessment of adverse events of the novel cardiovascular drug vericiguat: a real-world pharmacovigilance study based on FAERS. Expert Opinion on Drug Safety. 23(10). 1317–1325. 1 indexed citations
5.
6.
Huang, Ruoyu, et al.. (2024). Restoration of CD3 + CD56 + NKT‐like cell function by TIGIT blockade in inactive carrier and immune tolerant patients of chronic hepatitis B virus infection. European Journal of Immunology. 54(8). e2451046–e2451046. 1 indexed citations
7.
Zhang, Li, et al.. (2023). Attenuation of Sepsis-Induced Acute Kidney Injury by Exogenous H2S via Inhibition of Ferroptosis. Molecules. 28(12). 4770–4770. 17 indexed citations
8.
Yu, Yue, et al.. (2023). A nomogram for predicting postoperative overall survival of patients with lung squamous cell carcinoma: A SEER-based study. Frontiers in Surgery. 10. 1143035–1143035. 2 indexed citations
9.
Gong, Qian, Fang Wang, Xiaowen Feng, et al.. (2022). Protective effect of inhibiting necroptosis on gentamicin‐induced nephrotoxicity. The FASEB Journal. 36(9). e22487–e22487. 7 indexed citations
10.
Zhang, Yingzhi, Shiwen Tong, Shiying Li, et al.. (2022). Increased ILT2 expression contributes to dysfunction of CD56dimCD16+NK cells in chronic hepatitis B virus infection. Antiviral Research. 205. 105385–105385. 15 indexed citations
11.
Liu, Pengcheng, Xiaowen Feng, Xiaomin Zhao, et al.. (2022). Abnormal expression and clinical significance of surface receptors on natural killer cells in the peripheral blood of patients with non-small cell lung cancer. Neoplasma. 69(4). 931–939. 5 indexed citations
12.
Liu, Yang, et al.. (2021). Siglec-7 is an indicator of natural killer cell function in acute myeloid leukemia. International Immunopharmacology. 99. 107965–107965. 15 indexed citations
13.
Deng, Fuxue, Shiying Li, Xuefu Wang, et al.. (2021). NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes. Frontiers in Immunology. 12. 603192–603192. 6 indexed citations
14.
Chen, Feng, et al.. (2017). HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice. Scientific Reports. 7(1). 597–597. 51 indexed citations
15.
Chen, Feng, et al.. (2017). Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ. Scientific Reports. 7(1). 3556–3556. 12 indexed citations
16.
17.
Meng, Xiao‐Ming, Gui‐Ling Ren, Li Gao, et al.. (2016). Anti-fibrotic effect of wogonin in renal tubular epithelial cells via Smad3-dependent mechanisms. European Journal of Pharmacology. 789. 134–143. 30 indexed citations
18.
19.
Wang, Xuefu, Ziping Qi, Haiming Wei, Zhigang Tian, & Rui Sun. (2011). Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice. Transplant Immunology. 26(2-3). 156–162. 7 indexed citations
20.
Wang, Xuefu & Fuhua Cheng. (1997). Surface design based on Hermite spline interpolation with tension control and optimal twist vectors. Neural, Parallel & Scientific Computations archive. 5(1). 37–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanxiang Zhang Breakdown of academic impact, for papers by Junhua Gong Breakdown of academic impact, for papers by Jin Zhao Breakdown of academic impact, for papers by Jun Matsumoto Breakdown of academic impact, for papers by Nan Cheng Breakdown of academic impact, for papers by Jinkun Zhang Breakdown of academic impact, for papers by Jun Ren Breakdown of academic impact, for papers by Hiroshi Sakurai
Rankless by CCL
2026